Shannon T. Bailey

9.1k total citations · 3 hit papers
22 papers, 7.1k citations indexed

About

Shannon T. Bailey is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shannon T. Bailey has authored 22 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Shannon T. Bailey's work include Peroxisome Proliferator-Activated Receptors (5 papers), NF-κB Signaling Pathways (5 papers) and HER2/EGFR in Cancer Research (4 papers). Shannon T. Bailey is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (5 papers), NF-κB Signaling Pathways (5 papers) and HER2/EGFR in Cancer Research (4 papers). Shannon T. Bailey collaborates with scholars based in United States, Japan and United Kingdom. Shannon T. Bailey's co-authors include Mitchell A. Lazar, Ronadip R. Banerjee, Rexford S. Ahima, Christopher M. Wright, Claire M. Steppan, Elizabeth Brown, Mauricio J. Reginato, Myles Brown, Shamina M. Rangwala and Sankar Ghosh and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Shannon T. Bailey

20 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The hormone resistin links obesity to diabetes

2001 3.8k citations Claire M. Steppan, Shannon T. Bailey et al. Nature profile →
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response

1999 665 citations Chinyu Su, Xiaoming Wen et al. Journal of Clinical Investigation profile →
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo

2005 617 citations Jae‐Hyuck Shim, Changchun Xiao et al. Genes & Development profile →

Peers

Countries citing papers authored by Shannon T. Bailey

Since Specialization

Citations

This map shows the geographic impact of Shannon T. Bailey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon T. Bailey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon T. Bailey more than expected).

Fields of papers citing papers by Shannon T. Bailey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon T. Bailey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon T. Bailey. The network helps show where Shannon T. Bailey may publish in the future.

Co-authorship network of co-authors of Shannon T. Bailey

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon T. Bailey. A scholar is included among the top collaborators of Shannon T. Bailey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon T. Bailey. Shannon T. Bailey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of antibiotics on survival outcomes and risk of gastritis/colitis in patients with advanced-stage melanoma receiving anti-PD-1 therapy. 2023 ·Journal of Clinical Oncology ·Shannon T. Bailey, Thomas C. Havighurst, (unknown), Yusuf M. Mohamoud, (unknown), (unknown), (unknown), T. Vincent	0
2	Nucleosome dynamics define transcriptional enhancers 2020 ·UNC Libraries ·Keji Zhao, Mathieu Lupien, (unknown), Jason D. Lieb, Min Ni, Shannon T. Bailey, Piotr A. Mieczkowski, X. Shirley Liu, Myles Brown, Yongqing Zhang, Hyunjin Shin, Clifford A. Meyer, Housheng Hansen He, Qianben Wang, Gang Wei	0
3	High-quality whole-genome sequencing of FFPE samples. 2018 ·Journal of Clinical Oncology ·Shannon T. Bailey, Jim Lund, Hao Wang, (unknown), Hongye Sun, J. Gulcher	1
4	Abstract 4539: Novel feature selection strategies for enhanced predictive modeling and deep learning in the biosciences 2017 ·Cancer Research ·(unknown), Ryan Abo, Chang Liu, Zehua Chen, (unknown), Jike Cui, Chandri Yandava, Shannon T. Bailey, (unknown), Jeffery R. Gulcher, Thomas W. Chittenden	1
5	MUC1-C drives MYC in multiple myeloma 2016 ·Blood ·Ashujit Tagde, Hasan Rajabi, Audrey Bouillez, Maroof Alam, Reddy Gali, Shannon T. Bailey, Yu‐Tzu Tai, Teru Hideshima, Kenneth C. Anderson, David Avigan, Donald Küfe	64
6	Loss of Estrogen-Regulated microRNA Expression Increases HER2 Signaling and Is Prognostic of Poor Outcome in Luminal Breast Cancer 2014 ·Cancer Research ·Shannon T. Bailey, Thomas Westerling, Myles Brown	71
7	NF-κB Activation-Induced Anti-apoptosis Renders HER2-Positive Cells Drug Resistant and Accelerates Tumor Growth 2013 ·Molecular Cancer Research ·Shannon T. Bailey, Penelope Miron, Yoon Jong Choi, Bose Kochupurakkal, Gautam Maulik, Scott J. Rodig, Ruiyang Tian, Kathleen M. Foley, Teresa V. Bowman, Alexander Miron, Myles Brown, J. Dirk Iglehart, Debajit K. Biswas	42
8	Digital Quantification of Gene Expression in Sequential Breast Cancer Biopsies Reveals Activation of an Immune Response 2013 ·PLoS ONE ·Rinath Jeselsohn, Lillian Werner, Meredith M. Regan, Aquila Fatima, Lauren Gilmore, Laura C. Collins, Andrew H. Beck, Shannon T. Bailey, Housheng Hansen He, Gilles Buchwalter, Myles Brown, J. Dirk Iglehart, Andrea L. Richardson, Steven E. Come	11
9	Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer 2011 ·Cancer Cell ·Min Ni, Yiwen Chen, Elgene Lim, Hallie Wimberly, Shannon T. Bailey, Yuuki Imai, David L. Rimm, X. Shirley Liu, Myles Brown	294
10	GATA4 Regulates Estrogen Receptor-α-Mediated Osteoblast Transcription 2011 ·Molecular Endocrinology ·Gustavo A. Miranda‐Carboni, (unknown), Shannon T. Bailey, (unknown), Mirko Corselli, Bruno Péault, Susan A. Krum	47
11	Nucleosome dynamics define transcriptional enhancers 2010 ·Nature Genetics ·Housheng Hansen He, Clifford A. Meyer, Hyunjin Shin, Shannon T. Bailey, Gang Wei, Qianben Wang, Yong Zhang, Kexin Xu, Min Ni, Mathieu Lupien, Piotr A. Mieczkowski, Jason D. Lieb, Keji Zhao, Myles Brown, X. Shirley Liu	357
12	Growth factor stimulation induces a distinct ERα cistrome underlying breast cancer endocrine resistance 2010 ·Genes & Development ·Mathieu Lupien, Clifford A. Meyer, Shannon T. Bailey, Jérôme Eeckhoute, Jennifer Cook, Thomas Westerling, Xiaoyang Zhang, Jason S. Carroll, Daniel R. Rhodes, Xia Liu, Myles Brown	124
13	Nuclear factor-κB activation: a molecular therapeutic target for estrogen receptor–negative and epidermal growth factor receptor family receptor–positive human breast cancer 2007 ·Molecular Cancer Therapeutics ·(unknown), Qian Shi, Shannon T. Bailey, (unknown), Arthur B. Pardee, J. Dirk Iglehart, Debajit K. Biswas	71
14	'PPAR'ting ways with inflammation 2005 ·Nature Immunology ·Shannon T. Bailey, Sankar Ghosh	39
15	TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo breakdown → 2005 ·Genes & Development ·Jae‐Hyuck Shim, Changchun Xiao, (unknown), Shannon T. Bailey, P. Nagesh Rao, Matthew S. Hayden, Ki‐Young Lee, (unknown), Michael Steckel, Nobuyuki Tanaka, Gen Yamada, Shizuo Akira, Kunihiro Matsumoto, Sankar Ghosh	617
16	The hormone resistin links obesity to diabetes breakdown → 2001 ·Nature ·Claire M. Steppan, Shannon T. Bailey, (unknown), Elizabeth Brown, Ronadip R. Banerjee, Christopher M. Wright, (unknown), Rexford S. Ahima, Mitchell A. Lazar	3808
17	A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response breakdown → 1999 ·Journal of Clinical Investigation ·Chinyu Su, Xiaoming Wen, Shannon T. Bailey, Wen G. Jiang, Shamina M. Rangwala, Sue A. Keilbaugh, Anne Flanigan, Sreekant Murthy, Mitchell A. Lazar, Gary D. Wu	665
18	A Potent Antidiabetic Thiazolidinedione with Unique Peroxisome Proliferator-activated Receptor γ-activating Properties 1998 ·Journal of Biological Chemistry ·Mauricio J. Reginato, Shannon T. Bailey, (unknown), (unknown), Shin‐ichi Ishii, (unknown), Mitchell A. Lazar	164
19	Prostaglandins Promote and Block Adipogenesis through Opposing Effects on Peroxisome Proliferator-activated Receptor γ 1998 ·Journal of Biological Chemistry ·Mauricio J. Reginato, (unknown), Shannon T. Bailey, Mitchell A. Lazar	241
20	Interdomain communication regulating ligand binding by PPAR-γ 1998 ·Nature ·Dalei Shao, Shamina M. Rangwala, Shannon T. Bailey, (unknown), Mauricio J. Reginato, Mitchell A. Lazar	295

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact